Market Cap 1.07B
Revenue (ttm) 164.07M
Net Income (ttm) -372.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.84%
Debt to Equity Ratio 0.00
Volume 7,507,700
Avg Vol 9,474,286
Day's Range N/A - N/A
Shares Out 327.88M
Stochastic %K 12%
Beta 1.05
Analysts Strong Sell
Price Target $21.46

Latest News on IOVA

Top 3 Health Care Stocks That Are Set To Fly This Month

Mar 26, 2025, 7:06 AM EDT - 7 days ago

Top 3 Health Care Stocks That Are Set To Fly This Month

ARVN SLP


Iovance Biotherapeutics: Moving To The Next Phase

Oct 3, 2024, 2:43 PM EDT - 6 months ago

Iovance Biotherapeutics: Moving To The Next Phase


Iovance Biotherapeutics to Present at Upcoming Conferences

Sep 3, 2024, 5:00 PM EDT - 7 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences


Iovance (IOVA) stock price could jump by 30% after earnings

May 6, 2024, 9:28 AM EDT - 11 months ago

Iovance (IOVA) stock price could jump by 30% after earnings


Iovance Biotherapeutics Stock Rockets 41% Higher. Here's Why.

Feb 20, 2024, 12:52 PM EST - 1 year ago

Iovance Biotherapeutics Stock Rockets 41% Higher. Here's Why.


FDA Approves First Cellular Treatment For Advanced Melanoma

Feb 16, 2024, 4:16 PM EST - 1 year ago

FDA Approves First Cellular Treatment For Advanced Melanoma